Roble Belko & Company Inc raised its position in shares of iShares iBonds Dec 2031 Term Corporate ETF (NYSEARCA:IBDW – Free Report) by 169.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,531 shares of the company’s stock after buying an additional 35,539 shares during the quarter. Roble Belko & Company Inc owned about 0.05% of iShares iBonds Dec 2031 Term Corporate ETF worth $1,183,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Integrated Wealth Concepts LLC grew its position in shares of iShares iBonds Dec 2031 Term Corporate ETF by 5.4% in the 1st quarter. Integrated Wealth Concepts LLC now owns 28,640 shares of the company’s stock worth $594,000 after acquiring an additional 1,465 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of iShares iBonds Dec 2031 Term Corporate ETF by 47.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 143,481 shares of the company’s stock valued at $3,019,000 after acquiring an additional 46,291 shares in the last quarter. Ameriprise Financial Inc. raised its position in shares of iShares iBonds Dec 2031 Term Corporate ETF by 20.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,565,212 shares of the company’s stock valued at $32,846,000 after acquiring an additional 260,759 shares in the last quarter. 10Elms LLP raised its position in shares of iShares iBonds Dec 2031 Term Corporate ETF by 61.9% during the 3rd quarter. 10Elms LLP now owns 20,400 shares of the company’s stock valued at $433,000 after acquiring an additional 7,800 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in iShares iBonds Dec 2031 Term Corporate ETF by 5.2% during the third quarter. Parallel Advisors LLC now owns 268,716 shares of the company’s stock worth $5,702,000 after purchasing an additional 13,383 shares during the last quarter.
iShares iBonds Dec 2031 Term Corporate ETF Price Performance
iShares iBonds Dec 2031 Term Corporate ETF stock opened at $20.78 on Monday. The company has a fifty day moving average price of $20.86 and a two-hundred day moving average price of $21.03. iShares iBonds Dec 2031 Term Corporate ETF has a 12 month low of $20.64 and a 12 month high of $21.78.
iShares iBonds Dec 2031 Term Corporate ETF Profile
The iShares iBonds Dec 2031 Term Corporate ETF (IBDW) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index composed of USD-denominated, investment-grade corporate bonds maturing between January 1, 2031 and December 15, 2031. IBDW was launched on Jun 22, 2021 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares iBonds Dec 2031 Term Corporate ETF
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding IBDW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2031 Term Corporate ETF (NYSEARCA:IBDW – Free Report).
Receive News & Ratings for iShares iBonds Dec 2031 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2031 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
